FDA Probes Child Death Linked to Drug for Blood Clotting Disorder

(MedPage Today) — The FDA said it has received postmarketing reports of neutralizing antibodies to ADAMTS13, including one death, in patients with congenital thrombotic thrombocytopenic purpura (cTTP) who were treated with the recombinant ADAMTS13…

Source link : https://www.medpagetoday.com/hematologyoncology/hematology/118655

Author :

Publish date : 2025-11-21 20:16:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

FDA Probes Child Death Linked to Drug for Blood Clotting Disorder

Telehealth-Based Cancer Trial; AI-Based Cancer Biomarkers; Myeloma Survival Landmark

Primary Hyperparathyroidism Tied to Long-Term Cardiometabolic Risks

Related Posts

How Often Do Physicians Encounter ‘Difficult’ Patients?

Regimen Improves PFS in Highly Mutated Metastatic Colorectal Cancer

Multiple Sclerosis Risk May Start Before Birth

CAR-Like T Cells Enhance Tumor Response in Gastroesophageal Cancer

Less Favored Airway Device in Cardiac Arrest Had Higher Success Rate

Pompeii’s public baths were unhygienic until the Romans took over

How Often Do Physicians Encounter ‘Difficult’ Patients?

Regimen Improves PFS in Highly Mutated Metastatic Colorectal Cancer

Multiple Sclerosis Risk May Start Before Birth

CAR-Like T Cells Enhance Tumor Response in Gastroesophageal Cancer

Less Favored Airway Device in Cardiac Arrest Had Higher Success Rate

Pompeii’s public baths were unhygienic until the Romans took over

Court Orders HHS to Restore $12 Million in Funding for AAP Grants

HPV Vaccine Uptake Is Too Low for Herd Immunity

Categories

Archives